World's Best Scientists 2026 revealed!
Award Badge
Medicine
Israel
2026

D-Index & Metrics

Medicine

D-Index
117
Citations
47896
World Ranking
4222
National Ranking
8

Michael Aviram publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael Aviram sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 589 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael Aviram D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Aviram sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 117 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in Israel Leader Award
  • 2025 - Research.com Medicine in Israel Leader Award

Overview

Michael Aviram is affiliated with the Technion - Israel Institute of Technology in Israel. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on epidemiology, molecular biology, genetics, endocrinology, diabetes and metabolism, and physiology.

The main topics addressed in Aviram's body of work include:

  • Liver Disease Diagnosis and Treatment
  • Diet and metabolism studies
  • Diet, Metabolism, and Disease
  • Alcohol Consumption and Health Effects
  • Microbial metabolism and enzyme function
  • Endoplasmic Reticulum Stress and Disease
  • Eicosanoids and Hypertension Pharmacology

Notable recent publications by Michael Aviram include:

  • Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome, 2020, Science Translational Medicine
  • Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis, 2021, Cell Reports
  • Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis, 2022, Redox Biology
  • Soybean Oil Modulates the Gut Microbiota Associated with Atherogenic Biomarkers, 2020, Microorganisms
  • Editorial: Nitro-fatty acids: novel drug candidates for the co-treatment of atherosclerosis and nonalcoholic fatty liver disease, 2020, Current Opinion in Lipidology

Frequent co-authors collaborating with Aviram are:

  • Oren Rom
  • Yuhao Liu
  • Tony Hayek
  • Bo Wen
  • Duxin Sun

The scientist's work has been published in several recurring venues, including:

  • Current Opinion in Lipidology
  • Science Translational Medicine
  • Cell Reports
  • Redox Biology
  • Microorganisms

Best Publications

  • Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

    M Aviram;M Rosenblat;C L Bisgaier;R S Newton

  • Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E–deficient mice

    Michael Aviram;Leslie Dornfeld;Mira Rosenblat;Nina Volkova

  • Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation

    Michael Aviram;Mira Rosenblat;Diana Gaitini;Samy Nitecki

  • Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation

    B Fuhrman;A Lavy;M Aviram

  • Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.

    Michael Aviram;Mira Rosenblat;Scott Billecke;John Erogul

  • Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation.

    Jacob Vaya;Paula A. Belinky;Michael Aviram

  • Reduced Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice Following Consumption of Red Wine, or Its Polyphenols Quercetin or Catechin, Is Associated With Reduced Susceptibility of LDL to Oxidation and Aggregation

    Tony Hayek;Bianca Fuhrman;Jacob Vaya;Mira Rosenblat

  • Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure.

    Michael Aviram;Leslie Dornfeld

  • Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic Lesions PON1 Esterase and Peroxidase-Like Activities

    Michael Aviram;Emiliya Hardak;Jacob Vaya;Saeed Mahmood

  • Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer

    Allan J. Pantuck;John T. Leppert;Nazy Zomorodian;William Aronson

  • Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development.

    Michael Aviram;Mira Rosenblat

  • Ginger Extract Consumption Reduces Plasma Cholesterol, Inhibits LDL Oxidation and Attenuates Development of Atherosclerosis in Atherosclerotic, Apolipoprotein E-Deficient Mice

    Bianca Fuhrman;Mira Rosenblat;Tony Hayek;Raymond Coleman

  • Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages.

    Mira Rosenblat;Tony Hayek;Michael Aviram

  • Modified forms of low density lipoprotein and atherosclerosis

    Michael Aviram

  • Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages.

    Bianca Fuhrman;Avishay Elis;Michael Aviram

  • Pomegranate Juice Supplementation to Atherosclerotic Mice Reduces Macrophage Lipid Peroxidation, Cellular Cholesterol Accumulation and Development of Atherosclerosis

    Marielle Kaplan;Tony Hayek;Ayelet Raz;Raymond Coleman

  • Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

    Michael Aviram;Mira Rosenblat;Charles L Bisgaier;Roger S Newton

  • Human Serum Paraoxonase/Arylesterase’s Retained Hydrophobic N-Terminal Leader Sequence Associates With HDLs by Binding Phospholipids Apolipoprotein A-I Stabilizes Activity

    R C Sorenson;C L Bisgaier;M Aviram;C Hsu

  • Polyphenols and Human Health: A Prospectus

    Francesco Visioli;Catalina Alarcón De La Lastra;Cristina Andres-Lacueva;Michael Aviram

  • Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice

    Orit Rozenberg;Mira Rosenblat;Raymond Coleman;Diana M Shih

Frequent Co-Authors

Mira Rosenblat
Mira Rosenblat Technion – Israel Institute of Technology
Abraham Marmur
Abraham Marmur Technion – Israel Institute of Technology
Zeev Gross
Zeev Gross Technion – Israel Institute of Technology
Kevin Jon Williams
Kevin Jon Williams Temple University
Dan S. Tawfik
Dan S. Tawfik Weizmann Institute of Science
Y. Eugene Chen
Y. Eugene Chen University of Michigan–Ann Arbor
Raz Jelinek
Raz Jelinek Ben-Gurion University of the Negev
Richard J. Deckelbaum
Richard J. Deckelbaum Columbia University
Hanna Mandel
Hanna Mandel Rambam Health Care Campus
Edwin L. Bierman
Edwin L. Bierman University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey into medicine and healthcare careers doesn't always follow a single path. Many students explore alternative and online programs to align with their goals, schedules, or prior experience. Specialized degrees and unique pathways can open doors to rewarding roles in healthcare—all while offering flexibility.

For those considering nursing but seeking a streamlined admissions process, there are nursing schools that don't require teas or HESI exams. These programs allow prospective nurses to bypass common entrance tests and accelerate their start in the healthcare field.

If your interest is in healthcare management, many choose a healthcare administration accelerated degree to jumpstart careers in leadership or administration. These online programs are designed for those seeking faster entry into managerial positions without sacrificing educational quality.

Current registered nurses can advance their qualifications with adn to fnp bridge programs. These programs are tailored for ADN-credentialed nurses aiming to become Family Nurse Practitioners, often blending online coursework with local clinical experiences.

Another growing field is nutrition. Obtaining a nutrition bachelor degree online allows students to step into roles promoting health and wellness or to continue their studies in medical or allied health fields.

Best Scientists Citing Michael Aviram

Trending Scientists